Kazia Therapeutics Limited has announced a delay in filing its Annual Report on Form 20-F for the fiscal year ended June 30, 2025. The company cited the need for additional time to finalize consolidated financial statements and complete audit procedures, and expects to file the report within fifteen days of the original deadline.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kazia Therapeutics Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-260712), on October 31, 2025, and is solely responsible for the information contained therein.